Condition: MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
rs104894094 in
CDKN2A gene and
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2
PMID 10651484 1998 Five novel somatic CDKN2/p16 mutations identified in melanoma, glioma and carcinoma of the pancreas. Mutations in brief no. 170. Online.
PMID 7987387 1994 Germline p16 mutations in familial melanoma.
PMID 9328469 1997 Germline mutations of the CDKN2 gene in UK melanoma families.
PMID 11506491 2001 A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families.
PMID 8653684 1996 Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
PMID 8710906 1996 Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
PMID 12019208 2002 Germline mutation of ARF in a melanoma kindred.
PMID 9425228 1998 Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
PMID 19260062 2009 Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.
PMID 8595405 1995 Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.
PMID 14646619 2003 A novel L94Q mutation in the CDKN2A gene in a melanoma kindred.
PMID 10874641 1999 CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.